BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Actinium To Host Webinar To Provide Update On Actimab-A Phase II Clinical Trial

  September 21, 2016

   · 

  5 min read
• Drug Development

  BiondVax Pharmaceuticals Phase 2b European Trial: Last Patient Out

  September 21, 2016

   · 

  4 min read
• Drug Development

  Cerecor Inc. Announces Completion Of Enrollment In Phase II Clinical Trial With CERC-301 As An Oral, Adjunctive Treatment Of Major Depressive Disorder

  September 21, 2016

   · 

  4 min read
• FDA

  Sarepta Announces FDA Accelerated Approval Of EXONDYS 51 (Eteplirsen) Injection, An Exon Skipping Therapy To Treat Duchenne Muscular Dystrophy (DMD) Patients Amenable To Skipping Exon 51

  September 21, 2016

   · 

  9 min read
• Business

  Oncolinx Receives Three Months Of Free Bench On Demand Space At Mass Innovation Labs

  September 21, 2016

   · 

  3 min read
• Bio NC

  Mucodel Pharma Announces Successful Completion Of Buccal Naloxone Pilot Clinical Study

  September 21, 2016

   · 

  2 min read